Couverture de Pharmaceutical Executive Daily: FDA Plans to Remove Two Study Requirement for New Drug Approvals

Pharmaceutical Executive Daily: FDA Plans to Remove Two Study Requirement for New Drug Approvals

Pharmaceutical Executive Daily: FDA Plans to Remove Two Study Requirement for New Drug Approvals

Écouter gratuitement

Voir les détails

À propos de ce contenu audio

 In today’s Pharmaceutical Executive Daily, the FDA reportedly removes its two-study requirement for new drug approvals, Hims & Hers enters a $1 billion agreement to acquire Eucalyptus, and experts examine how FDA can help ease early-stage clinical trial bottlenecks.
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Aucun commentaire pour le moment